Search

Your search keyword '"Proteus mirabilis drug effects"' showing total 1,144 results

Search Constraints

Start Over You searched for: Descriptor "Proteus mirabilis drug effects" Remove constraint Descriptor: "Proteus mirabilis drug effects"
1,144 results on '"Proteus mirabilis drug effects"'

Search Results

1. Antibiotic profile classification of Proteus mirabilis using machine learning: An investigation into multidimensional radiomics features.

2. Tyramine Derivatives as Versatile Pharmacophores With Potent Biological Properties: Sex Hormone-Binding Globulin Inhibition, Colon Cancer Antimigration, and Antimicrobial Activity.

3. Synthesis, theoretical studies, antibacterial, and antibiofilm activities of novel azo-azomethine chelates against the pathogenic bacterium Proteus mirabilis.

4. Prevalence and antibiotic susceptibility patterns of uropathogens in men with prostate cancer and benign prostate hyperplasia from Southwestern Nigeria.

5. Genomic profiling of pan-drug resistant proteus mirabilis Isolates reveals antimicrobial resistance and virulence gene landscape.

6. Crude aqueous Proteus mirabilis extract with quorum sensing inhibitory activity can increase the susceptibility of multidrug resistant Pseudomonas aeruginosa to antimicrobials.

7. A novel PCR-based genotyping method for Proteus mirabilis - Intergenic region polymorphism analysis.

8. OXA-48-like carbapenemases in Proteus mirabilis - novel genetic environments and a challenge for detection.

9. Downregulation of Klebsiella pneumoniae RND efflux pump genes following indole signal produced by Escherichia coli.

10. Anti-inflammatory response to 1,8-Cineol and associated microbial communities in Otitis media patients.

11. Rosa × damascena Herrm. From Azaran region, Kashan: rich in saturated and unsaturated fatty acids with inhibitory effect against Proteus mirabilis.

12. Identification of mechanisms modulating chlorhexidine and octenidine susceptibility in Proteus mirabilis.

13. Anti-quorum Sensing and Anti-biofilm Effect of Nocardiopsis synnemataformans RMN 4 (MN061002) Compound 2,6-Di-tert-butyl, 1,4-Benzoquinone Against Biofilm-Producing Bacteria.

14. In vitro and in vivo study of antibacterial and anti-encrustation coating on ureteric stents.

15. Genetic characteristics of chromosomally integrated carbapenemase gene (bla NDM-1 ) in isolates of Proteus mirabilis.

16. Long-term antifouling surfaces for urinary catheters.

17. Copper affects virulence and diverse phenotypes of uropathogenic Proteus mirabilis.

18. Potential antivirulence activity of sub-inhibitory concentrations of ciprofloxacin against Proteus mirabilis isolates: an in-vitro and in-vivo study.

19. Emergence of extensive drug resistance and high prevalence of multidrug resistance among clinical Proteus mirabilis isolates in Egypt.

20. The risk factors, antimicrobial resistance patterns, and outcomes associated with extended-spectrum β-lactamases-Producing pathogens in pediatric urinary tract infection.

21. Assessment of Biofilm Forming Capability and Antibiotic Resistance in Proteus mirabilis Colonizing Indwelling Catheter.

22. Alhagi maurorum extract modulates quorum sensing genes and biofilm formation in Proteus mirabilis.

23. Anti- Proteus Activity, Anti-Struvite Crystal, and Phytochemical Analysis of Sida acuta Burm. F. Ethanolic Leaf Extract.

24. Talarodrides A-F, Nonadrides from the Antarctic Sponge-Derived Fungus Talaromyces sp. HDN1820200.

25. Molecular epidemiology of cefotaxime-resistant but ceftazidime-susceptible Enterobacterales and evaluation of the in vitro bactericidal activity of ceftazidime and cefepime.

26. Serum levels of immunoglobulin and complement in UTI of patients caused by Proteus mirabilis and using AgNPs as antiswarming.

27. Multidrug-resistant Proteus mirabilis isolates carrying bla OXA-1 and bla NDM-1 from wildlife in China: increasing public health risk.

28. Novel Dy 2 O 3 /ZnO-Au ternary nanocomposites: Green synthesis using pomegranate fruit extract, characterization and their photocatalytic and antibacterial properties.

29. Bruguiera gymnorhiza (L.) Lam. at the Forefront of Pharma to Confront Zika Virus and Microbial Infections-An In Vitro and In Silico Perspective.

30. Catalase Activity is Critical for Proteus mirabilis Biofilm Development, Extracellular Polymeric Substance Composition, and Dissemination during Catheter-Associated Urinary Tract Infection.

31. A Novel SXT/R391 Integrative and Conjugative Element Carries Two Copies of the bla NDM-1 Gene in Proteus mirabilis.

32. Clinical evaluation of the acuitas® AMR gene panel for rapid detection of bacteria and genotypic antibiotic resistance determinants.

33. From the Urinary Catheter to the Prevalence of Three Classes of Integrons, β -Lactamase Genes, and Differences in Antimicrobial Susceptibility of Proteus mirabilis and Clonal Relatedness with Rep-PCR.

34. Emergence of Imipenem Resistance in a CpxA-H208P-Variant-Producing Proteus mirabilis Clinical Isolate.

35. An investigation of the impact of triclosan adaptation on Proteus mirabilis clinical isolates from an Egyptian university hospital.

36. Isolation, characterization and antibiotic resistance of Proteus mirabilis from Belgian broiler carcasses at retail and human stool.

37. Synthesis, antitumor, antibacterial and urease inhibitory evaluation of new piperazinyl N-4 carbamoyl functionalized ciprofloxacin derivatives.

38. atpD gene sequencing, multidrug resistance traits, virulence-determinants, and antimicrobial resistance genes of emerging XDR and MDR-Proteus mirabilis.

39. Synergistic activity of weak organic acids against uropathogens.

40. Phytochemical analysis, antioxidant and antibacterial potential of some selected medicinal plants traditionally utilized for the management of urinary tract infection.

41. Antibacterial, antifungal and enzymatic activities of azithromycin-heavy metal complexes: Newly synthesized and characterized.

42. Metabolic Profiling of VOCs Emitted by Bacteria Isolated from Pressure Ulcers and Treated with Different Concentrations of Bio-AgNPs.

43. Surrogate testing of oral third-generation cephalosporin susceptibility to common uropathogens.

44. Molecular Characterization of β-Lactam Resistance and Antimicrobial Susceptibility to Possible Therapeutic Options of AmpC-Producing Multidrug-Resistant Proteus mirabilis in a University Hospital of Split, Croatia.

45. Amikacin and bacteriophage treatment modulates outer membrane proteins composition in Proteus mirabilis biofilm.

46. Anti-Biofilm Effect of Octenidine and Polyhexanide on Uropathogenic Biofilm-Producing Bacteria.

47. Synthesis, Characterization, Molecular Docking, In Vitro Biological Evaluation and In Vitro Cytotoxicity Study of Novel Thiazolidine-4-One Derivatives as Anti-Breast Cancer Agents.

48. Proteomic analysis deciphers the multi-targeting antivirulence activity of tannic acid in modulating the expression of MrpA, FlhD, UreR, HpmA and Nrp system in Proteus mirabilis.

49. Combination of urease inhibitor and antiseptic inhibits urea decomposition-induced ammonia production by Proteus mirabilis.

50. Diclofenac mitigates virulence of multidrug-resistant Staphylococcus aureus.

Catalog

Books, media, physical & digital resources